Edition:
United States

Aevi Genomic Medicine Inc (GNMX.OQ)

GNMX.OQ on NASDAQ Stock Exchange Global Market

0.99USD
14 Aug 2018
Change (% chg)

$0.01 (+1.02%)
Prev Close
$0.98
Open
$0.99
Day's High
$0.99
Day's Low
$0.99
Volume
1,833
Avg. Vol
21,769
52-wk High
$2.64
52-wk Low
$0.84

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.138
Mar '18 0.00 -0.147
FY 2017 Dec '17 0.00 -0.129
Sep '17 0.00 -0.232
Jun '17 0.00 -0.216
Mar '17 0.00 -0.294
FY 2016 Dec '16 0.00 -0.229
Sep '16 0.00 -0.285
Jun '16 0.00 -0.350
Mar '16 0.00 -0.338
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 2 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-18 3 0.00 0.00 0.00 0.00
Year Ending Dec-19 3 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Sep-18 3 -0.15 -0.14 -0.17 -0.37
Quarter Ending Dec-18 3 -0.15 -0.14 -0.16 -0.38
Year Ending Dec-18 3 -0.58 -0.56 -0.61 -1.11
Year Ending Dec-19 3 -0.89 -0.61 -1.27 -1.41
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 169.61 31.56
P/E High - Last 5 Yrs. -- 272.22 47.08
P/E Low - Last 5 Yrs. -- 94.99 24.92
Beta 0.87 0.77 0.84
Price to Sales (TTM) -- 267.24 8.27
Price to Book (MRQ) 3.80 15.25 3.85
Price to Tangible Book (MRQ) 3.80 24.89 5.90
Price to Cash Flow (TTM) -- 107.26 22.10
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.37 1.77
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.46 -6.48
Payout Ratio(TTM) -- 6.29 46.88

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 143.07 6.54
Sales (TTM) vs TTM 1 Yr. Ago -- 95.58 11.69
Sales - 5 Yr. Growth Rate -- 29.56 7.70
EPS (MRQ) vs Qtr. 1 Yr. Ago 36.23 67.56 17.85
EPS (TTM) vs TTM 1 Yr. Ago 36.93 -- --
EPS - 5 Yr. Growth Rate -- 44.45 7.85
Capital Spending - 5 Yr. Growth Rate -42.38 41.16 7.96

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.69 2.53
Current Ratio (MRQ) 4.05 6.20 3.60
LT Debt to Equity (MRQ) 0.00 19.89 11.17
Total Debt to Equity (MRQ) 0.00 23.69 14.44
Interest Coverage (TTM) -- -180.05 30.82

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.68 55.00
Gross Margin - 5 Yr. Avg. -- 52.50 53.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -188.08 15.79
Operating Margin (TTM) -- -1,117.16 -2.66
Operating Margin - 5 Yr. Avg. -- -201.21 10.98
Pre-Tax Margin (TTM) -- -1,002.27 -0.75
Pre-Tax Margin - 5 Yr. Avg. -- -202.65 11.15
Net Profit Margin (TTM) -- -992.09 -3.95
Net Profit Margin - 5 Yr. Avg. -- -200.58 7.50
Effective Tax Rate (TTM) -- 11.94 20.44
Effective Tax Rate - 5 Yr. Avg. -- 19.09 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,423,970 747,643,669
Net Income/Employee (TTM) -1,921,412 -2,152,945 87,203,463
Receivable Turnover (TTM) -- 16.83 5.67
Inventory Turnover (TTM) -- 2.26 3.64
Asset Turnover (TTM) 0.00 0.42 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -152.02 0.45 10.25
Return on Assets - 5 Yr. Avg. -86.59 2.37 11.10
Return on Investment (TTM) -197.29 1.42 12.88
Return on Investment - 5 Yr. Avg. -97.49 1.85 14.34
Return on Equity (TTM) -197.29 0.52 15.04
Return on Equity - 5 Yr. Avg. -100.32 -6.83 15.66
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 30.11 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aevi Genomic Medicine Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 23.41%
# of Holders: 53
Total Shares Held: 13,890,289
3 Mo. Net Change: 204,563
# New Positions: 3
# Closed Positions: 3
# Increased Positions: 7
# Reduced Positions: 5
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.